Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia
This study has been completed.
Study NCT00060502 Information provided by Centocor, Inc.
First Received: May 7, 2003 Last Updated: March 24, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cachexia
Pancreatic Neoplasms
Additional conditions recognized in this trial
Neoplasms
More general conditions related to this trial
Body Weight
Body Weight Changes
Digestive System Diseases
Digestive System Neoplasms
Emaciation
Endocrine Gland Neoplasms
Endocrine System Diseases
Neoplasms by Site
Pancreatic Diseases
Signs and Symptoms
Weight Loss
Interventions listed in this trial
Infliximab; Gemcitabine
Additional drug interventions recognized in this trial
Gemcitabine
Infliximab
More general drug interventions related to this trial
Anti-Infective Agents
Anti-Inflammatory Agents
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antirheumatic Agents
Antiviral Agents
Dermatologic Agents
Enzyme Inhibitors
Gastrointestinal Agents
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Centocor, Inc.
Back to top of Main Content
